Skip to main content

Table 5 Agreement rates between diagnostic tests results at the beginning and end of the sand fly season

From: Monitoring Leishmania infection and exposure to Phlebotomus perniciosus using minimal and non-invasive canine samples

ComparisonSand fly season
StartEnd
P-valueKappa95% CIPA (%)NA (%)OA (%)P-valueKappa95% CIPA (%)NA (%)OA (%)
A vs B0.0020.6710.501–0.84270.098.894.20.0160.7470.605–0.88877.697.094.7
A vs C< 0.0010.075− 0.031–0.18125.272.860.10.0410.019− 0.115–0.15318.782.170.7
A vs Da      < 0.001− 0.026− 0.138–0.08717.873.760.1
A vs E< 0.0010.014− 0.059–0.00921.953.641.2< 0.0010.002− 0.041–0.04524.224.924.5
A vs F< 0.0010.029− 0.007–0.06424.029.626.9< 0.001− 0.018− 0.058–0.02222.814.218.8
A vs G< 0.0010.037− 0.014–0.08824.341.734.1< 0.0010.008− 0.030–0.04635.324.623.6
B vs C< 0.0010.006− 0.074–0.08912.272.658.2< 0.0010.055− 0.078–0.18818.284.674.0
B vs Da      < 0.001− 0.049− 0.144–0.04610.974.760.6
B vs E< 0.0010.021− 0.031–0.07314.055.040.9< 0.001− 0.001− 0.038–0.03517.224.821.2
B vs F< 0.0010.016− 0.009–0.04013.829.022.1< 0.0010.008− 0.014–0.03018.116.517.3
B vs G< 0.0010.008− 0.032–0.04713.040.529.3< 0.0010.018− 0.007–0.04318.823.421.2
C vs Da      0.0070.002− 0.132–0.13227.171.158.7
C vs E< 0.0010.079− 0.044–0.20253.350.551.9< 0.001− 0.060− 0.128–0.00831.319.826.0
C vs F< 0.0010.015− 0.072–0.10355.626.844.7< 0.001− 0.013− 0.060–0.03434.814.426.0
C vs G< 0.0010.010− 0.004–0.20457.542.151.0< 0.001− 0.031− 0.089–0.02833.319.226.9
D vs Ea      < 0.0010.022− 0.051–0.09550.425.340.4
D vs Fa      < 0.001− 0.058− 0.123–0.00847.310.433.7
D vs Ga      < 0.001− 0.031− 0.104–0.04148.018.536.5
E vs F< 0.0010.4840.369–0.59885.260.278.40.0100.5800.408–0.75295.162.591.4
E vs G< 0.0010.5420.425–0.66085.268.279.80.5400.5050.334–0.67793.354.188.5
F vs G< 0.0010.5840.451–0.71691.266.786.10.1180.4940.304–0.68494.654.690.4
  1. aLeishmania DNA was not detected at the beginning of the phlebotomine sand fly season by conjunctival swab PCR
  2. Abbreviations: A, enzyme-linked immunosorbent assay; B, immunofluorescence antibody test; C, peripheral blood-polymerase chain reaction (PCR); D, conjunctival swab-PCR; E, 43 KDa yellow-related protein; F, 43 kDa yellow-related protein and 35.5 kDa apyrase; G, salivary gland homogenate; PA, positive agreement; NA, negative agreement; OA, overall agreement